Click for best price
Influenza Drugs Market Size, Share 2022
Market Analysis and Insights: Global Influenza Drugs Market
The global Influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Drugs market.
Global Influenza Drugs Scope and Market Size
Influenza Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Influenza Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Segment by Application
Adults
Chidren
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Influenza Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Influenza Drugs, with price, sales, revenue, and global market share of Influenza Drugs from 2019 to 2022.
Chapter 3, the Influenza Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Influenza Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Drugs.
Chapter 13, 14, and 15, to describe Influenza Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Influenza Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Influenza Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Influenza Drugs Product Introduction
1.2 Global Influenza Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Influenza Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Influenza Drugs Sales in Volume for the Year 2017-2028
1.3 United States Influenza Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Influenza Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Influenza Drugs Sales in Volume for the Year 2017-2028
1.4 Influenza Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Influenza Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Influenza Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Influenza Drugs Market Dynamics
1.5.1 Influenza Drugs Industry Trends
1.5.2 Influenza Drugs Market Drivers
1.5.3 Influenza Drugs Market Challenges
1.5.4 Influenza Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Influenza Drugs Market Segment by Type
2.1.1 Zanamivir
2.1.2 Oseltamivir Phosphate
2.1.3 Peramivir
2.1.4 Other Influenza Drugs
2.2 Global Influenza Drugs Market Size by Type
2.2.1 Global Influenza Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Influenza Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Influenza Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Influenza Drugs Market Size by Type
2.3.1 United States Influenza Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Influenza Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Influenza Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Influenza Drugs Market Segment by Application
3.1.1 Adults
3.1.2 Chidren
3.2 Global Influenza Drugs Market Size by Application
3.2.1 Global Influenza Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Influenza Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Influenza Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Influenza Drugs Market Size by Application
3.3.1 United States Influenza Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Influenza Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Influenza Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Influenza Drugs Competitor Landscape by Company
4.1 Global Influenza Drugs Market Size by Company
4.1.1 Top Global Influenza Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Influenza Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Influenza Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Influenza Drugs Price by Manufacturer (2017-2022)
4.2 Global Influenza Drugs Concentration Ratio (CR)
4.2.1 Influenza Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Influenza Drugs in 2021
4.2.3 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Influenza Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Influenza Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Influenza Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Influenza Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Influenza Drugs Market Size by Company
4.5.1 Top Influenza Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Influenza Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Influenza Drugs Sales by Players (2020, 2021 & 2022)
5 Global Influenza Drugs Market Size by Region
5.1 Global Influenza Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Influenza Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Influenza Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Influenza Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Influenza Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Influenza Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Influenza Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Influenza Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Influenza Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Influenza Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Influenza Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Influenza Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Influenza Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Bristol-Myers Squibb]
7.1.1 Bristol-Myers Squibb] Corporation Information
7.1.2 Bristol-Myers Squibb] Description and Business Overview
7.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
7.1.5 Bristol-Myers Squibb] Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Corporation Information
7.2.2 AstraZeneca Description and Business Overview
7.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca Influenza Drugs Products Offered
7.2.5 AstraZeneca Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Eli Lilly Influenza Drugs Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Roche
7.4.1 Roche Corporation Information
7.4.2 Roche Description and Business Overview
7.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Roche Influenza Drugs Products Offered
7.4.5 Roche Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Influenza Drugs Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Novartis
7.6.1 Novartis Corporation Information
7.6.2 Novartis Description and Business Overview
7.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Influenza Drugs Products Offered
7.6.5 Novartis Recent Development
7.7 Pfizer
7.7.1 Pfizer Corporation Information
7.7.2 Pfizer Description and Business Overview
7.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Pfizer Influenza Drugs Products Offered
7.7.5 Pfizer Recent Development
7.8 Sanofi Pasteur
7.8.1 Sanofi Pasteur Corporation Information
7.8.2 Sanofi Pasteur Description and Business Overview
7.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Sanofi Pasteur Influenza Drugs Products Offered
7.8.5 Sanofi Pasteur Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer Influenza Drugs Products Offered
7.9.5 Bayer Recent Development
7.10 Celgene
7.10.1 Celgene Corporation Information
7.10.2 Celgene Description and Business Overview
7.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celgene Influenza Drugs Products Offered
7.10.5 Celgene Recent Development
7.11 Seqirus
7.11.1 Seqirus Corporation Information
7.11.2 Seqirus Description and Business Overview
7.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Seqirus Influenza Drugs Products Offered
7.11.5 Seqirus Recent Development
7.12 Protein Sciences Corporation
7.12.1 Protein Sciences Corporation Corporation Information
7.12.2 Protein Sciences Corporation Description and Business Overview
7.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Protein Sciences Corporation Products Offered
7.12.5 Protein Sciences Corporation Recent Development
7.13 Serum Institute of India
7.13.1 Serum Institute of India Corporation Information
7.13.2 Serum Institute of India Description and Business Overview
7.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Serum Institute of India Products Offered
7.13.5 Serum Institute of India Recent Development
7.14 Emergent Biosolutions
7.14.1 Emergent Biosolutions Corporation Information
7.14.2 Emergent Biosolutions Description and Business Overview
7.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Emergent Biosolutions Products Offered
7.14.5 Emergent Biosolutions Recent Development
7.15 BioCryst Pharmaceuticals
7.15.1 BioCryst Pharmaceuticals Corporation Information
7.15.2 BioCryst Pharmaceuticals Description and Business Overview
7.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 BioCryst Pharmaceuticals Products Offered
7.15.5 BioCryst Pharmaceuticals Recent Development
7.16 Alvogen
7.16.1 Alvogen Corporation Information
7.16.2 Alvogen Description and Business Overview
7.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Alvogen Products Offered
7.16.5 Alvogen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Influenza Drugs Industry Chain Analysis
8.2 Influenza Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Influenza Drugs Distributors
8.3 Influenza Drugs Production Mode & Process
8.4 Influenza Drugs Sales and Marketing
8.4.1 Influenza Drugs Sales Channels
8.4.2 Influenza Drugs Distributors
8.5 Influenza Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Influenza Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Influenza Drugs Market Trends
Table 3. Influenza Drugs Market Drivers
Table 4. Influenza Drugs Market Challenges
Table 5. Influenza Drugs Market Restraints
Table 6. Global Influenza Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Influenza Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Influenza Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Influenza Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Influenza Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Influenza Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Influenza Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Influenza Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Influenza Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Influenza Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2021)
Table 18. Top Players of Influenza Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Influenza Drugs Product Type
Table 20. Date of International Manufacturers Enter into Influenza Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Influenza Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Influenza Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Influenza Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Influenza Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Influenza Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Influenza Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Influenza Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Influenza Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Influenza Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Influenza Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Influenza Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Influenza Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Influenza Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Influenza Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Influenza Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Influenza Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Influenza Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Influenza Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Influenza Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Influenza Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bristol-Myers Squibb] Corporation Information
Table 43. Bristol-Myers Squibb] Description and Business Overview
Table 44. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Bristol-Myers Squibb] Influenza Drugs Product
Table 46. Bristol-Myers Squibb] Recent Development
Table 47. AstraZeneca Corporation Information
Table 48. AstraZeneca Description and Business Overview
Table 49. AstraZeneca Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. AstraZeneca Product
Table 51. AstraZeneca Recent Development
Table 52. Eli Lilly Corporation Information
Table 53. Eli Lilly Description and Business Overview
Table 54. Eli Lilly Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Eli Lilly Product
Table 56. Eli Lilly Recent Development
Table 57. Roche Corporation Information
Table 58. Roche Description and Business Overview
Table 59. Roche Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Roche Product
Table 61. Roche Recent Development
Table 62. GlaxoSmithKline Corporation Information
Table 63. GlaxoSmithKline Description and Business Overview
Table 64. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. GlaxoSmithKline Product
Table 66. GlaxoSmithKline Recent Development
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Novartis Product
Table 71. Novartis Recent Development
Table 72. Pfizer Corporation Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Pfizer Product
Table 76. Pfizer Recent Development
Table 77. Sanofi Pasteur Corporation Information
Table 78. Sanofi Pasteur Description and Business Overview
Table 79. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Sanofi Pasteur Product
Table 81. Sanofi Pasteur Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. Celgene Corporation Information
Table 88. Celgene Description and Business Overview
Table 89. Celgene Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Celgene Product
Table 91. Celgene Recent Development
Table 92. Seqirus Corporation Information
Table 93. Seqirus Description and Business Overview
Table 94. Seqirus Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Seqirus Product
Table 96. Seqirus Recent Development
Table 97. Protein Sciences Corporation Corporation Information
Table 98. Protein Sciences Corporation Description and Business Overview
Table 99. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Protein Sciences Corporation Product
Table 101. Protein Sciences Corporation Recent Development
Table 102. Serum Institute of India Corporation Information
Table 103. Serum Institute of India Description and Business Overview
Table 104. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Serum Institute of India Product
Table 106. Serum Institute of India Recent Development
Table 107. Emergent Biosolutions Corporation Information
Table 108. Emergent Biosolutions Description and Business Overview
Table 109. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Emergent Biosolutions Product
Table 111. Emergent Biosolutions Recent Development
Table 112. BioCryst Pharmaceuticals Corporation Information
Table 113. BioCryst Pharmaceuticals Description and Business Overview
Table 114. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. BioCryst Pharmaceuticals Product
Table 116. BioCryst Pharmaceuticals Recent Development
Table 117. Alvogen Corporation Information
Table 118. Alvogen Description and Business Overview
Table 119. Alvogen Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Alvogen Product
Table 121. Alvogen Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Influenza Drugs Customers List
Table 125. Influenza Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Influenza Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Influenza Drugs Sales 2017-2028 (K MT)
Figure 5. United States Influenza Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Influenza Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Influenza Drugs Sales 2017-2028 (K MT)
Figure 8. United States Influenza Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Influenza Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Influenza Drugs Report Years Considered
Figure 11. Product Picture of Zanamivir
Figure 12. Product Picture of Oseltamivir Phosphate
Figure 13. Product Picture of Peramivir
Figure 14. Product Picture of Other Influenza Drugs
Figure 15. Global Influenza Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Influenza Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Influenza Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Influenza Drugs Sales by Type (2017-2028) & (K MT)
Figure 19. Global Influenza Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Influenza Drugs Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Influenza Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Influenza Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Influenza Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Influenza Drugs Sales by Type (2017-2028) & (K MT)
Figure 25. United States Influenza Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Influenza Drugs Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Adults
Figure 28. Product Picture of Chidren
Figure 29. Global Influenza Drugs Market Share by Application in 2022 & 2028
Figure 30. Global Influenza Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Influenza Drugs Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Influenza Drugs Sales by Application (2017-2028) & (K MT)
Figure 33. Global Influenza Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Influenza Drugs Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Influenza Drugs Market Share by Application in 2022 & 2028
Figure 36. United States Influenza Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Influenza Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Influenza Drugs Sales by Application (2017-2028) & (K MT)
Figure 39. United States Influenza Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Influenza Drugs Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Influenza Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Influenza Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Influenza Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Influenza Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Influenza Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Influenza Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Influenza Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Influenza Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Influenza Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Influenza Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Influenza Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Influenza Drugs Value Chain
Figure 75. Influenza Drugs Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
